Uterine carcinosarcoma, also referred to as malignant mixed Müllerian tumor, is a rare and highly aggressive neoplasm ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and ...

Nonbloody vaginal discharge can also be a manifestation of endometrial carcinoma and occurs in approximately 10% of patients. Pelvic pain and/or mass and weight loss usually occur in the later ...

Cadonilimab plus lenvatinib showed promising antitumor activity in patients with advanced endometrial cancer who have experienced disease progression after prior platinum-based chemotherapy,” said ...

A new report has found gynaecological cancers have been among the poorest funded for almost two decades — these women hope to ...

It is well recognized that, in many cases, endometrial carcinoma is a well differentiated tumor bearing a marked resemblance to the parent organ tissue. Elton 14 noted in such tumors appearing ...

Meanwhile, Keytruda has an FDA green light in advanced endometrial carcinoma that is microsatellite instability-high (MSI-H) or dMMR in March 2022, as well as in a combination regimen alongside ...

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

As 19 women are diagnosed with a gynaecological cancer every day, advocates are calling for more funding to improve ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which tumor-infiltrating immune cells regulate endometrial carcinoma (EC). As one of the ...